Why Most University Equity Policies Destroy Spinout Value Before the First Term Sheet
Most university equity policies in spinouts are structured to deter investors, not attract them. Here's what goes wrong and how to fix it.
A. Kovacs Topic
spinouts
8 posts tagged spinouts from Commercializing Science.
A. Kovacs More on spinouts
Why Most University Spinout Boards Are Structured to Fail From Day One
Most university spinout boards are assembled for optics, not governance. Here's why the wrong structure kills promising companies before they scale.
A. KovacsWhy Most Grant-to-Spinout Transitions Fail Before the Company Even Forms
The gap between a funded research project and a viable spinout company destroys more potential than bad science ever does. Here's what actually goes wrong.
A. KovacsWhy Most Sublicensing Provisions Quietly Transfer Your Leverage to Someone Else
Sublicensing provisions in university license agreements often hand control to licensees by default. Here's what to negotiate before it's too late.
A. KovacsWhy Most Field-of-Use Restrictions in License Agreements Create More Problems Than They Solve
Field-of-use restrictions in university license agreements promise focused commercialization but routinely strangle deal value and block better applications from reaching market.
A. KovacsWhy Most Startup Equity Structures Break University Spinouts Before They Launch
Equity splits between founders, universities, and early investors derail more spinouts than bad science. Here's what actually works.
A. KovacsWhy Due Diligence Kills More University Spinouts Than Bad Science
How mismatched expectations between VCs and university spinouts create a death spiral during due diligence.
A. KovacsThe Valley of Death Is Real and We're Still Not Talking About It Honestly
University research dies between the lab and the market at staggering rates. The reasons are structural, not accidental, and most proposed fixes miss the point entirely.
A. Kovacs Browse more topics